# clm_3F5BAE27E768

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: total_equity  
value: 29,353,600,000 United States dollar  
valid_from: 2024-12-31  
valid_to: 2025-03-31  
published: 2025-02-05  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_B1CBF863516B  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals total equity: 29,353,600,000 United States dollar", as of 2024-12-31 (until 2025-03-31). Claim clm_3F5BAE27E768, https://asof.is/claim/clm_3F5BAE27E768, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000180422025000011/0001804220-25-000011-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-K FY2024, filed 2025-02-05  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000180422025000011/0001804220-25-000011-index.htm (primary, SEC EDGAR 10-K FY2024, published 2025-02-05)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 29,325,900,000 United States dollar | valid 2024-09-30 to 2024-12-31 | conf 0.95 | superseded | superseded_by [clm_3F5BAE27E768](/claim/clm_3F5BAE27E768.md) | [clm_F515E2AB009D](/claim/clm_F515E2AB009D.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.